DHC heads into its June 10 earnings print with short sellers quietly rebuilding positions and a lone analyst upgrade landing fresh this week — a small divergence worth watching in a name that has already run more than 50% year-to-date.
The clearest tension right now is between price momentum and deteriorating fundamentals. DHC closed at $8.50, up 3.5% on the day but down 3.6% on the week — a wobble that echoes broader healthcare REIT weakness. Peers LTC and OHI each fell more than 7% on the week. SBRA and VTR dropped over 10%. DHC's relative resilience is notable given the sector headwind, but the stock is pulling back from its recent highs and the short book is growing into it.
Short interest has climbed steadily. At 4.1% of free float — roughly 9.9 million shares — SI has risen around 10% over the past month, including a 3.4% weekly increase. The trend is consistent rather than violent. From a low near 8 million shares in early May, short sellers have been methodically adding. The borrow market shows no stress: availability runs at 1,528% of estimated short interest, meaning there are roughly fifteen shares available to borrow for every one currently shorted. Cost to borrow has drifted higher by 22% over the week to reach 0.51%, but at that level it remains negligible — there is no meaningful friction for new shorts entering the name. The ORTEX short score of 44.6 has ticked up each day for two weeks, reaching its highest recent reading on June 2, reflecting the building positioning.
Options traders are not hedging into the earnings release. The put/call ratio of 0.21 is fractionally below its 20-day average of 0.22 and 1.5 standard deviations below the mean — options flow skews toward calls, not puts. That sits well below the 52-week high of 1.10, suggesting the options market carries no meaningful defensive posture heading into the June 10 print. The two stories — rising short interest, call-skewed options — point in different directions, making the setup genuinely ambiguous.
The analyst backdrop adds a further bullish data point this week. Maxim Group raised its price target from $10.00 to $10.50 this morning, maintaining a Buy rating — the most current action on the stock. That $10.50 target sits 24% above the current price of $8.50. Earlier in the year, B. Riley held a Buy with a $8.50 target (now at current levels), and RBC maintained Sector Perform with a $6.00 target. The mean target of $7.25 reflects data that has not been fully updated and should be read cautiously — the more recent Maxim move tells a more constructive story. Factor scores give a different shade: forward EPS expectations rank in the 96th percentile on a year-on-year basis, though 30-day EPS momentum ranks in just the 23rd percentile, suggesting estimates have stalled even as the longer-term trend improves.
Institutional ownership tells a story of concentrated conviction. BlackRock holds nearly 10% of shares, Flat Footed LLC and RMR Group each hold close to 9.6%. Silver Point Capital and H/2 Credit Manager together own another 12.5%. Davidson Kempner and Vanguard entities added materially in Q1. The ownership base is dominated by credit-oriented and special-situation managers rather than traditional REIT generalists — a composition consistent with a name still navigating a multi-year recovery story rather than a stable income compounder. Dividends have not been paid since early 2022, and there is no indication that income distribution is back on the near-term agenda.
Recent earnings reactions have been consistently positive for DHC. The last print on May 5 delivered a 6.8% one-day move and a 7.7% five-day return. The preceding Q4 release saw a 4.2% one-day gain and a 7.4% five-day return. That consistent post-print rally pattern frames the June 10 event as the next key inflection. What to watch: whether the combination of rebuilding short interest, a fresh analyst upgrade, and a stock pulling back into earnings creates the conditions for a repeat positive reaction — or whether the sector-wide pressure and stalling estimate momentum finally weigh on a name that has outrun most of its peers by a considerable margin.
See the live data behind this article on ORTEX.
Open DHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
